Search Results Search Sort by RelevanceMost Recent In the Literature Jun 2023 Patient-Centered Approaches to Using BMI to Evaluate Gender-Affirming Surgery Eligibility Whitney Riley Linsenmeyer, PhD, RD, LD and Sarah Garwood, MD Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based. AMA J Ethics. 2023;25(6):E398-406. doi: 10.1001/amajethics.2023.398. In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202. In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308. In the Literature Jul 2009 Clinical Research in Low- and Middle-Income Countries Mark Boyd, MD, FRACP There are advantages and objections to conducting clinical trials in middle-income nations and possible approaches to overcoming the objections. Virtual Mentor. 2009;11(7):511-515. doi: 10.1001/virtualmentor.2009.11.7.jdsc1-0907. In the Literature Mar 2010 The Physician-Researcher's Dilemma Hana Akselrod The traditional triple threat model of academic physician careers can help global health researchers balance research commitments and the duty to care. Virtual Mentor. 2010;12(3):192-196. doi: 10.1001/virtualmentor.2010.12.3.jdsc1-1003 In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.
In the Literature Jun 2023 Patient-Centered Approaches to Using BMI to Evaluate Gender-Affirming Surgery Eligibility Whitney Riley Linsenmeyer, PhD, RD, LD and Sarah Garwood, MD Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based. AMA J Ethics. 2023;25(6):E398-406. doi: 10.1001/amajethics.2023.398.
In the Literature Feb 2012 Barriers and Biases: Ethical Considerations for Providing Emergency Contraception to Adolescents in the Emergency Department Rebecca C. Thilo When adolescents seek emergency contraception in the emergency room, social judgment on the part of clinicians can hamper treatment. Virtual Mentor. 2012;14(2):121-125. doi: 10.1001/virtualmentor.2012.14.2.jdsc1-1202.
In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.
In the Literature Jul 2009 Clinical Research in Low- and Middle-Income Countries Mark Boyd, MD, FRACP There are advantages and objections to conducting clinical trials in middle-income nations and possible approaches to overcoming the objections. Virtual Mentor. 2009;11(7):511-515. doi: 10.1001/virtualmentor.2009.11.7.jdsc1-0907.
In the Literature Mar 2010 The Physician-Researcher's Dilemma Hana Akselrod The traditional triple threat model of academic physician careers can help global health researchers balance research commitments and the duty to care. Virtual Mentor. 2010;12(3):192-196. doi: 10.1001/virtualmentor.2010.12.3.jdsc1-1003
In the Literature Feb 2010 Risks and Benefits of Innovative Off-Label Surgery Caitlin E. Weber Controversy associated with off-label application of drugs and devices has arisen as innovative treatments clash with responsible regulation. Virtual Mentor. 2010;12(2):97-101. doi: 10.1001/virtualmentor.2010.12.2.jdsc1-1002.